United States · FDA National Drug Code directory
Ramipril
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68382-145_d155011e-1c8b-4ac2-9a2f-6d62127620c3
- Product NDC
- 68382-145
- Form
- CAPSULE
- Composition / generic term
- Ramipril
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20101120
- Source listing expiry
- 20271231
Source-listed ingredients
- RAMIPRIL — 2.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 BOTTLE (68382-145-01) · 68382-145-01
- 500 CAPSULE in 1 BOTTLE (68382-145-05) · 68382-145-05
- 30 CAPSULE in 1 BOTTLE (68382-145-06) · 68382-145-06
- 90 CAPSULE in 1 BOTTLE (68382-145-16) · 68382-145-16
- 100 BLISTER PACK in 1 CARTON (68382-145-77) / 1 CAPSULE in 1 BLISTER PACK (68382-145-30) · 68382-145-77
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →